Chinas weight-loss drug makers take on global giants as Novo Nordisk patent expires Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss market Novo Nordisks blockbuster semaglutide, which generated about US$35 billion in global revenue last year, lost patent protection in China on March 20, clearing the way for rivals
Patients affected by the ban should consult with their healthcare providers to discuss alternative treatment options and explore potential financial assistance programs to mitigate the impact of the ban on their access to necessary medications
For general context, the following principles apply to the storage of reconstituted injectable peptides in clinical settings: Reconstituted solutions are typically stored under refrigeration at 28C and protected from direct light [5] Freeze-thaw cycles after reconstitution can disrupt peptide structure and should be avoided [5] Vials should be kept sealed and handled using aseptic technique to prevent microbial contamination Each vial should be clearly labelled with the date and time of reconstitution These principles are provided for contextual understanding only
But emerging research suggests the medications offer impressive health benefits aside from lowering blood sugar levels and supporting weight loss
How long do I need to stay on these peptides
This was a 40-week study using the 12 mg dose